The results of the present research illustrate that the interdiction of LncRNA-H19 is critical for the hyperglycemia-induced impairment of angiogenesis by regulating the vitality of Akt activation, and the use of H19EMNVs successfully sustained the angiogenic ability. The gene discussed is AKT1; the disease is Hyperglycemia.